ACADIA Pharmaceuticals Inc (ACAD)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	230,794	112,235	22,815	-4,585	-73,379	-154,386	-127,476	-164,164	-223,596	-222,190	-206,625	-216,683	-170,439	-192,944	-263,542	-263,843	-286,586	-275,823	-235,345	-248,426
Revenue (ttm)	US$ in thousands	957,797	929,236	890,534	813,806	726,437	631,886	550,901	520,229	517,235	511,503	512,401	493,059	484,145	474,394	463,359	458,241	441,755	419,074	393,083	366,185
Operating profit margin		24.10%	12.08%	2.56%	-0.56%	-10.10%	-24.43%	-23.14%	-31.56%	-43.23%	-43.44%	-40.32%	-43.95%	-35.20%	-40.67%	-56.88%	-57.58%	-64.87%	-65.82%	-59.87%	-67.84%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $230,794K ÷ $957,797K
= 24.10%

ACADIA Pharmaceuticals Inc's operating profit margin has shown a notable improvement over the reported periods, transitioning from negative values to positive margins. The company experienced a significant improvement in profitability, with the operating profit margin increasing from -67.84% in March 2020 to 24.10% in December 2024. This positive trend indicates that ACADIA Pharmaceuticals Inc has been able to effectively manage its operating expenses and generate higher levels of operating income relative to its revenues. The steady increase in operating profit margin suggests improved operational efficiency and effectiveness in the company's cost management strategies, leading to stronger financial performance over time.